Anatara Lifesciences Ltd (ASX:ANR) Finalises Draft Protocol for IBS Clinical Trial
Anatara Lifesciences (ASX:ANR) is pleased to provide an update on the protocol for its clinical trial in irritable bowel syndrome (IBS) for its GaRP dietary supplement.